Interferon alpha and 13 cis retinoid acid in the therapy of metastatic renal cell carcinoma.

被引：0
|
作者：
Ostrizkova, L [1 ]
Kocak, I [1 ]
Palacova, M [1 ]
Kebedeova, D [1 ]
机构：
[1] Masaryk Mem Canc Inst, Brno, Czech Republic
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
359
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [11] Phase II study of interferon-alpha (IFN), Gleevec or Iressa patients with metastatic renal cell carcinoma.
    Amato, R
    Kareidy, M
    Marsh, L
    Truong, L
    Shen, S
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9030S - 9030S
  • [12] The combination of 13-cis-retinoic acid and interferon alpha 2a with radiation therapy in squamous cell carcinoma of the cervix
    Kavanaugh, JJ
    Lippman, SM
    ParedesEspinoza, M
    Erikson, AO
    DelgadilloMadrueno, F
    ParedesCasillas, P
    Kudelka, AP
    Hong, WK
    Lotan, R
    Hittelman, W
    Ahn, WS
    Holdener, E
    Schleuniger, U
    Silva, EG
    Tornos, CS
    Krakoff, IH
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1996, 6 (06) : 439 - 444
  • [13] Patient priorities and expectations of systemic therapy in metastatic renal cell carcinoma.
    Battle, Dena
    Vaishampayan, Ulka N.
    Msaouel, Pavlos
    Pal, Sumanta Kumar
    Zhang, Tian
    Staehler, Michael D.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [14] Combined interferon alpha with levamisole in patients with metastatic renal cell carcinoma
    Aksoy H.
    Baltaci S.
    Türkölmez K.
    Seçkiner I.
    Bedük Y.
    International Urology and Nephrology, 2001, 33 (3) : 457 - 459
  • [15] An analysis of STAT3 polymorphism on outcomes of interferon-alpha treatment in patients with metastatic renal cell carcinoma.
    Eto, M.
    Kamba, T.
    Miyake, H.
    Fujisawa, M.
    Yoshida, K.
    Uemura, H.
    Tsukamoto, T.
    Katsuoka, Y.
    Matsubara, A.
    Nishimura, K.
    Nakamura, T.
    Ogawa, O.
    Naito, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [16] Interferon in metastatic renal cell carcinoma
    Fosså, SD
    SEMINARS IN ONCOLOGY, 2000, 27 (02) : 187 - 193
  • [17] A phase II study with 13 CIS retinoic acid alpha interferon and CDDP in 28 squamous cell carcinoma
    Gravis, G
    PechGourg, F
    Cappiello, MA
    Resbeut, M
    Viallat, JR
    Seitz, JF
    Camerlo, J
    Maraninchi, D
    Viens, P
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 585 - 585
  • [18] 13-CIS-RETINOIC ACID AND INTERFERON ALPHA-2A - EFFECTIVE COMBINATION THERAPY FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE SKIN
    LIPPMAN, SM
    PARKINSON, DR
    ITRI, LM
    WEBER, RS
    SCHANTZ, SP
    OTA, DM
    SCHUSTERMAN, MA
    KRAKOFF, IH
    GUTTERMAN, JU
    HONG, WK
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (04) : 235 - 241
  • [19] Efficacy of incomplete metastasectomy with targeted therapy in patients with metastatic renal cell carcinoma.
    Orlova, Rashida
    Borisov, Pavel
    Karlov, Petr A.
    Shkolnik, Michail
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [20] Effects of 13-cis-retinoic acid on chemoimmunotherapy of metastatic renal cell carcinoma -: Results of a retrospective analysis
    Roigas, J
    Deger, S
    Taymoorian, K
    Wille, AH
    Johannsen, M
    Türk, I
    Schnorr, D
    Loening, SA
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (02) : 157 - 163
12345